Heather Savelle
Investor Relations Contact at TSCAN THERAPEUTICS, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gavin MacBeath | M | 54 | 6 years | |
Timothy Barberich | M | 76 | 5 years | |
Stephen Biggar | M | 53 | 3 years | |
Barbara Klencke | M | 66 | 1 years | |
Katina Dorton | F | 66 | 3 years | |
R. Woods | M | 57 | 1 years | |
Zoran Zdraveski | M | 54 | 3 years | |
Gabriela Gruia | M | 67 | 3 years | |
Leiden Dworak | M | - | 2 years | |
Maghan Meyers | F | - |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Danforth Advisors LLC, Argot Partners LLC is a strategic communications consultancy exclusively focused on the life sciences. The company is based in New York, NY, with offices in the Boston area. The company provides a broad suite of services to over 90 clients across all stages of their corporate evolution. The company's services include corporate communications and investor relations, public relations and digital media, IPO, data, partnership, product approval, commercial launch, M&A, and special situations communications, executive visibility and training, ESG communications, event planning, and a full suite of creative services. The company was founded in 2007 by David M.F. Pitts, Andrea F. Rabney. Andrea F. Rabney has been the CEO since 2007. Argot Partners was acquired by Danforth Advisors LLC on January 04, 2023. | 6 years |
Jason Amello | M | 55 | - | |
Ann Hargraves | F | - | 4 years | |
Samuel Martin | M | - |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Danforth Advisors LLC, Argot Partners LLC is a strategic communications consultancy exclusively focused on the life sciences. The company is based in New York, NY, with offices in the Boston area. The company provides a broad suite of services to over 90 clients across all stages of their corporate evolution. The company's services include corporate communications and investor relations, public relations and digital media, IPO, data, partnership, product approval, commercial launch, M&A, and special situations communications, executive visibility and training, ESG communications, event planning, and a full suite of creative services. The company was founded in 2007 by David M.F. Pitts, Andrea F. Rabney. Andrea F. Rabney has been the CEO since 2007. Argot Partners was acquired by Danforth Advisors LLC on January 04, 2023. | 7 years |
Shrikanta Chattopadhya | M | - | - | |
Ray Lockard | M | - | 1 years | |
Justin McCue | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Joseph deBethizy | M | 74 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 15 years |
Brian Silver | M | 55 | 2 years | |
David Southwell | M | 63 | 5 years | |
Mark B. Skaletsky | M | 75 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 12 years |
Stephen Hill | M | 65 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 3 years |
Patrick C. Rock | M | 64 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | - |
Michael Barrett | M | 81 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 11 years |
Ittai Harel | M | 56 | 4 years | |
Peter A. Zorn | M | 53 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 10 years |
Ralph Snyderman | M | 84 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 6 years |
Geoffrey C. Dunbar | M | 77 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 11 years |
G. Steven Burrill | M | 79 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 7 years |
Jeffrey P. Brennan | M | 66 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | 10 years |
Joe Rayne | M | - |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Danforth Advisors LLC, Argot Partners LLC is a strategic communications consultancy exclusively focused on the life sciences. The company is based in New York, NY, with offices in the Boston area. The company provides a broad suite of services to over 90 clients across all stages of their corporate evolution. The company's services include corporate communications and investor relations, public relations and digital media, IPO, data, partnership, product approval, commercial launch, M&A, and special situations communications, executive visibility and training, ESG communications, event planning, and a full suite of creative services. The company was founded in 2007 by David M.F. Pitts, Andrea F. Rabney. Andrea F. Rabney has been the CEO since 2007. Argot Partners was acquired by Danforth Advisors LLC on January 04, 2023. | 4 years |
Natalie Wildenradt | F | - |
Argot Partners LLC
Argot Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Danforth Advisors LLC, Argot Partners LLC is a strategic communications consultancy exclusively focused on the life sciences. The company is based in New York, NY, with offices in the Boston area. The company provides a broad suite of services to over 90 clients across all stages of their corporate evolution. The company's services include corporate communications and investor relations, public relations and digital media, IPO, data, partnership, product approval, commercial launch, M&A, and special situations communications, executive visibility and training, ESG communications, event planning, and a full suite of creative services. The company was founded in 2007 by David M.F. Pitts, Andrea F. Rabney. Andrea F. Rabney has been the CEO since 2007. Argot Partners was acquired by Danforth Advisors LLC on January 04, 2023. | 3 years |
Shane Maltbie | M | 42 | 2 years | |
William Desmarais | M | 54 | 2 years | |
Debora Barton | M | 48 | 2 years | |
Jim Murray | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Heather Savelle
- Personal Network